info@bioxplor.com

Accelerating COVID-19 data-driven discovery

COVID-19 Engine (free)

Protein/Gene Engine (free)

Data Discovery SERVICES

COVID-19 DNA Data Study

COMPUTATIONAL DRUG DISCOVERY - NATURAL LANGUAGE PROCESSING - MACHINE LEARNING

Patient Responder Prediction for Clinical Trials

Drug Repositioning / Indication Expansion

Novel Target Identification & Prioritization

Pathway Analysis & Novel Pathway Discovery

Virual Drug Phenotypic Screening

Target Binding Site Prediction

Safety & Toxicity Analysis

Bioinformatics & Cheminformatics

API Access to BioXplor's Knowledgebase

BioXplor is offering data-driven discovery services to industry, academic, clinical and government laboratories involved in COVID-19 R&D, as well as other teams looking to accelerate or maintain their ongoing programs during the pandemic. BioXplor has a very experienced inhouse team as an extended team of trusted partners. Our clients include leading pharma companies such as Novartis, Bayer and Merck, as well as smaller biotechs and academic groups.

Data-Driven Discovery Services

Cloud-Based Platform Integration

Project Feasibility Form

- Step 1 of 2

Project Feasibility Form

Select Data-Driven Discovery Service(s): *

Patient Responder Prediction for Clinical Trials
Drug Repositioning / Indication Expansion
Novel Target Identification & Prioritization
Safety & Toxicity Analysis
Pathway Analysis & Novel Pathway Discovery
Virtual Drug Screening
Target Binding Site Prediction
Bioinformatics & Cheminformatics
API access to Knowledgebase
Cloud-Based Platform Integration
Other

Please provide a full description of your project:

Please upload a sample of your dataset or any other details that will help our team review your request:

Click or drag a file to this area to upload.

Project Administration

What are your required timelines for delivery of this project: *

Describe your organisation type: *

Do you have a budget already approved for this project? *

Name *

First

Last

Email *

Email

Confirm Email

Phone

Address

Address Line 1

Address Line 2

City

State / Province / Region

Country

Website / URL

Email

Data-Driven Drug Discovery

BioXplor was founded in January 2017 and is backed by UC Berkeley Skydeck, Merck & European Innovation Council (Horizon 2020) accelerators, amongst other investment partners. The 10 person strong team has combined expertise in computer science and biomedical science applied to drug discovery, which are the core components of what we do, in equal measure. We are passionate about developing data-driven approaches to accelerate and improve Life Science R&D.

At BioXplor we are building an integrated CompBio platform to accelerate discoveries and reduce failures in drug discovery. The integrated discovery platform works by generating obvious and non-obvious knowledge on a topic from structured and unstructured data using proprietary natural language processing and machine learning algorithms. Our next stage is validating predictions in vitro via engineered disease models, patient data and bio-activity screening for drug discovery. We have successfully applied the platform for Indication Expansion, Drug Repositioning, Pathway Analysis, Target ID, and Clinical Trial Responder ID, with clients including top 5 pharma and biotech companies. BioXplor’s technology is available for licensing and we operate a CRO model.

Partners

Dusseldorf, Germany

Berkeley, California

Dublin, Ireland

Copyright 2020 BioXplor, Inc.

All Rights Reserved.